Aktis Oncology Inc. (AKTS)
NASDAQ: AKTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 18.00 0.00%
AKTS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.00B
- EPS (TTM)
- -$1.70
- Dividend yield
- None
- 52-week range
- 14.72 – 34.19
- Day range
- 17.72 – 18.35
- Volume / Avg
- 294.10K / 370.56K
- Beta
- —
- Shares outstanding
- 53.75M
- Next earnings
- Nov 12, 2026
52-week range
AKTS stock today
Shares of Aktis Oncology (AKTS) finished higher on Oct 7 at $18.00, a gain of 0.78% or $0.14 per share, versus the S&P 500's 0.22% decline. Shares are 47.4% below their 52-week high of $34.19, set on Jun 30, 2026 and 22.3% above the 52-week low of $14.72, near the bottom of the past year's range. Aktis Oncology has posted a net loss over the last twelve months (EPS of -$1.70), so its P/E ratio is not meaningful.
Aktis Oncology's next earnings report is expected on Nov 12, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Aktis Oncology
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2026
Earnings
Earnings history- Next report
- Nov 12, 2026
Aktis Oncology peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SVRASavara Inc. | 4.88 | +4.95% | $1.00B | vs AKTS |
| PCRXPacira BioSciences Inc. | 25.20 | +1.78% | $1.00B | vs AKTS |
| SPTXSeaport Therapeutics Inc. | 17.93 | +3.22% | $959.80M | vs AKTS |
| LTGOLatigo Biotherapeutics Inc. | 15.52 | -4.55% | $1.03B | vs AKTS |
| OPKOPKO Health Inc. | 1.39 | -4.79% | $1.04B | vs AKTS |
| KURAKura Oncology Inc. | 10.67 | +1.33% | $949.21M | vs AKTS |
| ANROAlto Neuroscience Inc. | 23.52 | -0.72% | $922.97M | vs AKTS |
| MLTXMoonLake Immunotherapeutics Class A | 10.77 | -1.64% | $916.60M | vs AKTS |
Indexes, lists and sector
Largest Health Care stocks
Aktis Oncology stock FAQ
What is Aktis Oncology's stock price today?
AKTS last traded at $18.00 as of Oct 7, 4:00 PM EDT, up 0.78% on the day. Prices are delayed at least 15 minutes.
When is Aktis Oncology's next earnings date?
Aktis Oncology is expected to report earnings on Thursday, November 12, 2026.
What is the AKTS 52-week high?
The 52-week high for AKTS is $34.19 and the 52-week low is $14.72. The stock is currently 47.4% below its high.